US Broker Ratings

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Look at Growth Potential and Analyst Consensus

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is making significant strides in the drug manufacturing industry, particularly in the specialty and..

Insmed Incorporated (INSM): Investor Outlook on Potential 76.57% Upside in Biotech Giant

For investors seeking exposure in the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) offers a compelling opportunity with potential upside reflected in its analyst ratings and target..

DaVita Inc. (DVA) Stock Analysis: High ROE and Current Valuation Pose Questions for Investors

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector specializing in medical care facilities, primarily focused on kidney dialysis services, has been capturing investor..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 35% Potential Upside in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector, particularly in the medical devices industry, with a formidable market capitalization of $10.88 billion. Specializing..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Growth Potential with a Strategic Focus in Biotechnology

Investors seeking to dive into the healthcare sector might find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) an enticing opportunity. As a leading player in the biotechnology industry,..

BridgeBio Pharma (BBIO) Stock Analysis: Uncovering a 32.5% Potential Upside for Biotech Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing investor attention with its substantial market capitalization of $15.12 billion and a..

Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Innovator with Positive Analyst Consensus

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices industry, stands out in the healthcare sector with its robust market presence and innovative..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and Potential 18% Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the healthcare sector specializing in the production of both generic and specialty drugs, presents an intriguing..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unveiling a 15.68% Upside Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector specializing in medical devices, is capturing investor attention with its robust market presence..

Nuvalent, Inc. (NUVL) Stock Analysis: Unpacking the $9.79 Billion Market Cap and Future Potential

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, has piqued the interest of investors with its $9.79 billion market capitalization. Specializing in innovative therapies for cancer..

Vaxcyte, Inc. (PCVX) Stock Analysis: Biotechnology Innovator with an 86.68% Potential Upside

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing the attention of investors with its promising pipeline of innovative vaccines and a robust potential upside of 86.68%. As a..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 28.68% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors with its..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a Potential 8.59% Upside with Robust Revenue Growth

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, specializes in medical instruments and supplies. With a market capitalization of $14.47 billion,..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a Focus on Future Growth

Baxter International Inc. (BAX), a stalwart in the healthcare sector, continues to be a focal point for investors interested in medical instruments and supplies. With a..

Eli Lilly and Company (LLY) Stock Analysis: Investor Outlook on a $1.08 Trillion Healthcare Giant

Eli Lilly and Company (NYSE: LLY) continues to capture the attention of investors, boasting a robust market capitalization of $1.08 trillion. This pharmaceutical titan, headquartered in..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring an 85% Upside Potential in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, is capturing investor attention with its ambitious therapeutic innovations and a striking potential upside..

Masimo Corporation (MASI) Stock Analysis: Evaluating the Growth Potential in the Medical Device Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specifically within medical devices, presents a compelling case for investors seeking exposure to innovative patient..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Growth Potential in a Competitive Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) is making waves in the healthcare sector with a market capitalization of $15.92 billion, underscoring its formidable presence in the diagnostics..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating a 52-Week Low with Strategic Insights

Regencell Bioscience Holdings Limited (NASDAQ: RGC) has drawn attention with its current share price of $6.37, which sits at the lower end of its 52-week range..

Alkermes plc (ALKS) Stock Analysis: Navigating Growth in the Healthcare Sector Amidst Strong Revenue Performance

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, has been capturing investor interest with its robust revenue growth and diverse product portfolio. The..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds